CD160 antigen
| GO Term | Evidence Code | PMID |
|---|---|---|
| adaptive immune response | ||
| mucosal immune response | ||
| positive regulation of natural killer cell cytokine production | ||
| positive regulation of natural killer cell cytokine production | ||
| positive regulation of natural killer cell mediated immune response to tumor cell |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| signaling receptor binding | ||
| signaling receptor binding | ||
| protein binding | ||
| kinase binding | ||
| kinase binding |
| Gene Ontology |
|---|
| regulation of adaptive immune response |
| InterPro |
|---|
| CD160 ANTIGEN |
| Immunoglobulin-like domain superfamily |
| Immunoglobulin-like fold |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025